These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29104073)

  • 1. Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
    Pérez PD; Ma Z; Hamilton C; Sánchez C; Mørk A; Pehrson AL; Bundgaard C; Zhang N
    Neuropharmacology; 2018 Jan; 128():379-387. PubMed ID: 29104073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
    Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C
    Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
    Waller JA; Chen F; Sánchez C
    Neuropharmacology; 2016 Apr; 103():143-54. PubMed ID: 26702943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
    Jensen JB; du Jardin KG; Song D; Budac D; Smagin G; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):148-59. PubMed ID: 24284262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sertraline, duloxetine, vortioxetine, and idazoxan in the rat affective bias test.
    Refsgaard LK; Haubro K; Pickering DS; Stuart SA; Robinson ES; Andreasen JT
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3763-3770. PubMed ID: 27572627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
    Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
    Sanchez C; Asin KE; Artigas F
    Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
    du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
    Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
    Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Jaeschke RR; Sendek K; Styczeń K; Datka W; Koperny M
    Pharmacol Rep; 2017 Aug; 69(4):595-601. PubMed ID: 28499187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
    Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C
    J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
    Pehrson AL; Leiser SC; Gulinello M; Dale E; Li Y; Waller JA; Sanchez C
    Eur J Pharmacol; 2015 Apr; 753():19-31. PubMed ID: 25107284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
    Li Y; Raaby KF; Sánchez C; Gulinello M
    Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
    Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
    David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
    Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.
    Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C
    Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.